Quarterly report · Q3
4539.TEDINET S100SOUB
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.1bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥31.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥24.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | −¥36m | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥192m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥125m | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥58m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥549m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥142m | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥971m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥104m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥339m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥684m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥104m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥684m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥50.9bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥48.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥50.0bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.2bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥30.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥18.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥19.2bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.6bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥28.89 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.17 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.07 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥189.62 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-58.82 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 36.8% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.3% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-12-31 | ¥849m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-12-31 | ¥846m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-12-31 | ¥92m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥11m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥11m |
| jpcrp040300-q3r_E00957-000Medicinereportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥22.2bn |
| jpcrp040300-q3r_E00957-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥22.2bn |
| jpcrp040300-q3r_E00957-000Medicinereportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥9m |
| jpcrp040300-q3r_E00957-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-12-31 | −¥128m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥23.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥23.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥11m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | −¥36m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥719m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥719m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥21m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥9m |
| jpcrp040300-q3r_E00957-000Medicinereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥23.3bn |
| jpcrp040300-q3r_E00957-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥23.3bn |
| jpcrp040300-q3r_E00957-000Medicinereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9m |
| jpcrp040300-q3r_E00957-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥170m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥24.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥24.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥192m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 405
| Item | Context | Value | Unit |
|---|---|---|---|
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -224000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 112000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 406000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 205000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -13000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -12000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 168000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 306000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 852000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 410000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 852000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 410000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Advertising expenses sga | Prior1YTDDuration | 40000000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 51000000 | JPY |
| Traveling and transportation expenses sga | Prior1YTDDuration | 238000000 | JPY |
| Traveling and transportation expenses sga | CurrentYTDDuration | 259000000 | JPY |
| Salaries sga | Prior1YTDDuration | 1994000000 | JPY |
| Salaries sga | CurrentYTDDuration | 1911000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 69000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 48000000 | JPY |
| Commission fee sga | Prior1YTDDuration | 997000000 | JPY |
| Commission fee sga | CurrentYTDDuration | 919000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 1631000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 1482000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00957-000MedicineReportableSegmentsMember | 23295000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 719000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 24015000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 24015000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00957-000MedicineReportableSegmentsMember | 9000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 0 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 9000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -9000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00957-000MedicineReportableSegmentsMember | 23305000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 719000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 24024000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -9000000 | JPY |
| Net sales | Prior1YTDDuration | 24015000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00957-000MedicineReportableSegmentsMember | 170000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 21000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 192000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 192000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00957-000MedicineReportableSegmentsMember | 22223000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 846000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 23069000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |